Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued on October 6, 2020, addresses West Coast Nuclear Pharmacy, a company involved in the distribution or preparation of drugs, presumably radiopharmaceuticals given the "nuclear pharmacy" designation. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the detailed violations and required corrective actions, the complete warning letter would need to be reviewed.